TipRanks
Advertisement

FMTM - ETF AI Analysis

Compare

Top Page

FMTM

MarketDesk Focused U.S. Momentum ETF (FMTM)

Rating:69Neutral
Price Target:―
FMTM’s rating suggests it is a solid but not top-tier momentum-focused ETF, supported by strong contributors like Medpace Holdings and NetApp, which bring robust financial performance, positive earnings sentiment, and growth in high-margin and AI-related areas. Other key holdings such as Natera, Illumina, and Thermo Fisher add to the fund’s quality through strong technical momentum and strategic initiatives, though valuation and profitability concerns, along with weaker names like Avantor facing declining revenue and weak momentum, hold the overall rating back. The main risk is that many holdings share similar issues around high valuations and profitability challenges, which can increase volatility if market sentiment toward these types of stocks turns negative.
Positive Factors
Strong Top Holdings
Many of the largest positions, especially in technology and health care, have shown strong year-to-date gains, helping drive the fund’s overall performance.
Momentum-Focused Strategy
The ETF targets U.S. stocks with strong recent price momentum, which can benefit investors when market trends continue in the same direction.
Sector Diversification Beyond Tech
While technology is the largest slice, the fund also holds meaningful stakes in industrials, financials, health care, and materials, spreading risk across several parts of the economy.
Negative Factors
Heavy U.S. Concentration
Almost all assets are invested in U.S. companies, so the fund offers little protection if the U.S. market weakens relative to other regions.
Technology Sector Dependence
With a large share of the portfolio in technology stocks, the ETF is vulnerable if that sector experiences a downturn.
Higher-Than-Core Expense Ratio
The fund’s expense ratio is higher than many broad market index ETFs, which means a larger slice of returns goes toward fees each year.

FMTM vs. SPDR S&P 500 ETF (SPY)

FMTM Summary

The MarketDesk Focused U.S. Momentum ETF (FMTM) is an actively managed fund that invests in U.S. companies showing strong recent price gains, a theme known as momentum investing. It focuses on larger and mid-sized stocks across the total U.S. market, with a big tilt toward technology and industrials. Well-known holdings include Dell Technologies and Goldman Sachs. Investors might consider FMTM if they want growth potential from stocks that have been doing well recently, while still holding a mix of sectors. A key risk is that momentum stocks can fall quickly if trends reverse, and the fund can go up and down sharply with the stock market.
How much will it cost me?The MarketDesk Focused U.S. Momentum ETF (FMTM) has an expense ratio of 0.45%, which means you’ll pay $4.50 per year for every $1,000 you invest. This is slightly higher than average because it’s an actively managed fund, where experts select stocks to try to outperform the market.
What would affect this ETF?The MarketDesk Focused U.S. Momentum ETF (FMTM) could benefit from strong growth in the technology and health care sectors, which make up significant portions of its portfolio, especially if innovation and consumer demand continue to drive these industries forward. However, rising interest rates or economic slowdowns could negatively impact momentum-driven strategies and sectors like consumer cyclical and financials, which are sensitive to broader economic conditions. Regulatory changes or geopolitical tensions affecting U.S. markets may also influence the ETF's performance.

FMTM Top 10 Holdings

FMTM is leaning heavily into U.S. health care momentum, with Illumina and Natera setting the pace as rising stars in genomics and diagnostics, giving the fund much of its current spark. RingCentral and NetApp add a tech twist, with cloud and AI themes helping performance stay lively rather than one‑note. On the flip side, Avantor looks more like a weak link, with softer fundamentals that can tug on returns. Overall, this is a U.S.-centric, health care–tilted momentum play, with a supporting cast of tech names keeping the engine humming.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Semtech3.70%$10.39M$18.08B174.71%
69
Neutral
Marvell3.66%$10.28M$249.64B213.94%
76
Outperform
Everpure3.66%$10.27M$50.87B63.90%
64
Neutral
NetApp3.65%$10.23M$46.31B92.04%
76
Outperform
Marathon Petroleum3.58%$10.05M$124.20B135.80%
66
Neutral
Okta3.52%$9.86M$38.11B135.34%
75
Outperform
Palo Alto Networks3.47%$9.74M$331.76B85.20%
73
Outperform
HF Sinclair Corporation3.47%$9.74M$20.56B120.92%
68
Neutral
Dynatrace3.44%$9.65M$17.29B23.50%
77
Outperform
Dell Technologies3.42%$9.59M$368.11B251.89%
65
Neutral

FMTM Technical Analysis

Technical Analysis Sentiment
Positive
Last Price―
Price Trends
50DMA
39.03
Positive
100DMA
39.79
Positive
200DMA
37.99
Positive
Market Momentum
MACD
0.27
Negative
RSI
60.47
Neutral
STOCH
56.49
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FMTM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.05, equal to the 50-day MA of 39.03, and equal to the 200-day MA of 37.99, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 60.47 is Neutral, neither overbought nor oversold. The STOCH value of 56.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FMTM.

FMTM Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$280.54M0.45%
69
Neutral
――$973.72M0.59%
68
Neutral
――$945.43M0.30%
73
Outperform
――$868.16M0.10%
69
Neutral
――$861.65M0.45%
74
Outperform
――$798.12M0.22%
60
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FMTM
MarketDesk Focused U.S. Momentum ETF
39.97
11.13
38.59%
SYLD
Cambria Shareholder Yield ETF
―
―
―
SEUS
SEI QiM U.S. Equity Factor Allocation Active ETF
―
―
―
AAUB
Alpha Architect US Equity 4 ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
AVTM
Avantis Total Equity Markets ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement